Neurons expressing somatostatin receptor 1 (SSTR1) represent an important population in the central nervous system that mediates the widespread inhibitory effects of somatostatin. SSTR1 is one of five somatostatin receptor subtypes (SSTR1-5) that belong to the G-protein coupled receptor family [1]. These neurons are widely distributed throughout the brain and play critical roles in regulating neurotransmitter release, neuronal excitability, and various cognitive functions. The somatostatin system acts as a major inhibitory neuromodulator, comparable in importance to GABA but with distinct mechanisms and functions.
The SSTR1 gene is located on chromosome 14p13.1 in humans and encodes a 391-amino acid protein [2]. The receptor contains:
Somatostatin (also known as somatotropin release-inhibiting factor, SRIF) exists in two biologically active forms:
Both forms bind to all SSTR subtypes with varying affinities, though SSTR1 has higher affinity for SST-14.
SSTR1 activates multiple intracellular signaling pathways:
SSTR1-expressing neurons are found throughout the CNS:
| Brain Region | Expression Level | Primary Function |
|---|---|---|
| Cerebral Cortex | High | Inhibitory modulation |
| Hippocampus | High | Memory regulation |
| Thalamus | Moderate | Sensory processing |
| Hypothalamus | Moderate | Neuroendocrine control |
| Brainstem | Variable | Autonomic regulation |
| Cerebellum | Low | Motor coordination |
SSTR1 is expressed in both neurons and glial cells:
SSTR1 neurons regulate synaptic transmission through:
The inhibition is mediated through:
In the hippocampus and cortex, SSTR1 neurons play important roles:
In the hypothalamus, SSTR1 neurons regulate:
SSTR1 in the spinal cord and brainstem:
Somatostatin system dysfunction is strongly implicated in Alzheimer's disease:
Somatostatin Deficiency:
Mechanisms:
Therapeutic Potential:
SSTR1 is a target in epilepsy treatment:
Antiepileptic Effects:
Mechanisms:
The somatostatin system may be affected in Parkinson's disease:
SSTR1 dysfunction is implicated in mood disorders:
Somatostatin Analogs:
Clinical Applications:
Potential Uses:
Hannon, J.P., et al. (2002). International Union of Pharmacology. LXVI. Somatostatin receptors. Pharmacological Reviews, 54(4), 645-671 ↩︎
Epelbaum, J., et al. (2009). Somatostatin and Alzheimer's disease. Progress in Neuropsychopharmacology and Biological Psychiatry, 33(6), 1054-1063 ↩︎
Vezzani, A., et al. (2000). The role of somatostatin in seizures and epilepsy: experimental evidence and clinical implications. The Cerebellum, 1(1), 43-52 ↩︎